Shares of CME Group Inc. (NASDAQ:CME – Get Free Report) have received a consensus rating of “Reduce” from the fifteen brokerages that are currently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating on the company. The average 1 year price target among brokers that have covered the stock in the last year is $238.93.
A number of equities research analysts have recently issued reports on CME shares. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research report on Friday, February 14th. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the company from $255.00 to $250.00 in a research report on Monday, January 6th. Oppenheimer lifted their price target on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Raymond James upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective for the company in a research report on Monday. Finally, Royal Bank of Canada lifted their price objective on CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 13th.
Read Our Latest Research Report on CME Group
Insiders Place Their Bets
Institutional Trading of CME Group
Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in CME Group by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock worth $7,952,273,000 after purchasing an additional 326,623 shares during the period. Geode Capital Management LLC boosted its position in CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider’s stock worth $1,946,717,000 after purchasing an additional 104,697 shares during the period. Price T Rowe Associates Inc. MD boosted its position in CME Group by 89.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock worth $1,923,047,000 after purchasing an additional 3,921,278 shares during the period. Norges Bank purchased a new stake in CME Group during the 4th quarter worth $1,107,389,000. Finally, FIL Ltd boosted its position in CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider’s stock worth $947,821,000 after purchasing an additional 61,908 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Price Performance
Shares of CME opened at $260.43 on Wednesday. The stock’s 50 day moving average is $241.25 and its two-hundred day moving average is $231.60. CME Group has a twelve month low of $190.70 and a twelve month high of $263.65. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $93.85 billion, a PE ratio of 26.93, a P/E/G ratio of 6.76 and a beta of 0.53.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Research analysts anticipate that CME Group will post 10.49 earnings per share for the current year.
CME Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a $1.25 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.92%. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s payout ratio is presently 51.71%.
CME Group announced that its board has approved a stock buyback program on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- Financial Services Stocks Investing
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Using the MarketBeat Dividend Tax Calculator
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.